Dillman R O, Koziol J A
Cancer Res. 1983 Jan;43(1):417-21.
We analyzed results of 22 in vitro parameters of immunocompetence in 72 cancer patients and 73 healthy controls. We then applied three statistical methodologies (discriminant analysis, logistic regression analysis, and recursive partitioning) in an effort to select the best predictors of immunosuppression. Using either of two definitions of immunosuppression (deviation by more than 1 standard deviation from the control mean on any assay, or having a diagnosis of advanced cancer), the same variables were selected. The best predictors were percentage of lymphocytes, percentage of suppressor cells, pokeweed mitogen stimulation, percentage of Ia+ cells, and number of helper cells. By all three methods, immunosuppressed and immunocompetent individuals were selected with 95 to 97% accuracy using a decision tree with these five tests as variables. In a cohort of individuals with incomplete data, the three methods still accurately classified the two groups with 70 to 83% accuracy. We conclude that a much smaller battery of tests can be used to identify immunosuppressed individuals for purposes of evaluation of responses to immune modulating agents.
我们分析了72名癌症患者和73名健康对照者的22项免疫能力体外参数结果。然后我们应用了三种统计方法(判别分析、逻辑回归分析和递归划分),以努力选择免疫抑制的最佳预测指标。使用免疫抑制的两种定义中的任何一种(任何检测中偏离对照均值超过1个标准差,或诊断为晚期癌症),选择出了相同的变量。最佳预测指标是淋巴细胞百分比、抑制细胞百分比、商陆有丝分裂原刺激、Ia +细胞百分比和辅助细胞数量。通过所有这三种方法,以这五项检测作为变量构建决策树,对免疫抑制和免疫能力正常的个体进行选择时,准确率达到了95%至97%。在一组数据不完整的个体中,这三种方法仍能以70%至83%的准确率准确地将两组进行分类。我们得出结论,为了评估对免疫调节剂的反应,可以使用一组规模小得多的检测来识别免疫抑制个体。